Clinical Trials
173 trialsCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Qurgen Inc.
Study on Early Auxiliary Diagnosis and Postoperative Recurrence Monitoring of Breast Cancer
Singlera Genomics Inc.
Heroine01
Advanced Imaging Projects, LLC
Multi-Reader Multi-Case, Retrospective Study to Evaluate Effectiveness of CadAI-B for Breast
BeamWorks Inc.
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases
RemeGen Co., Ltd.
Real World Evaluation of Lunit INSIGHT MMG Technology
Lunit Inc.
A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2
RemeGen Co., Ltd.
To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.
Changchun GeneScience Pharmaceutical Co., Ltd.
Tear Based Sample Collection Breast Cancer Detection
Namida Lab
Mass Balance Study of TQB3616
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Evaluation of TaiHao Breast Ultrasound Diagnosis Software RN-CES Descartes
TaiHao Medical Inc.
URODETECT-WP1
Novosanis NV
Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer
Beijing Biostar Pharmaceuticals Co., Ltd.
Minnelide 101
Minneamrita Therapeutics LLC
IMX-110 in Patients With Advanced Solid Tumors
Immix Biopharma, Inc.
Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Early Detection of Breast Cancer
Datar Cancer Genetics Inc
A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer
Jiangsu HengRui Medicine Co., Ltd.
FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
MARIO-3
Infinity Pharmaceuticals, Inc.
A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer
Betta Pharmaceuticals Co., Ltd.
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Validation of a Tear-based Screening Assay for Breast Cancer
Namida Lab
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Namida Lab
Study of TFX06 in Women With Advanced Breast Cancer.
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
COBRIS
GE Healthcare
Discovering Factors in Metastatic Breast Cancer Patients' Clinical Trial Experiences
Power Life Sciences Inc.
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
COMPULSE
NeoDynamics AB
Evaluation of the Bexaâ„¢ Breast Examination (BBE)
Sure, Inc.
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
ANGLeD
Angiochem Inc
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer
Chongqing Precision Biotech Co., Ltd
A Phase â… b/â…¡ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.
Jiangsu HengRui Medicine Co., Ltd.
Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy
Blau Farmaceutica S.A.
URODETECT-WP3
Novosanis NV
Intraoperative Use of ClearEdge Device in Breast Conserving Surgery
LS BioPath
CADENCE
MiRXES Pte Ltd
A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer
Shanghai Miracogen Inc.
Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials
Power Life Sciences Inc.
Study of SHR6390 in Renal Insufficiency and Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd.
WEE1
Impact Therapeutics, Inc.
A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of a Single Intravenous Infusion of BCD-178 or Perjeta® in Healthy Volunteers
Biocad
G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
G1 Therapeutics, Inc.
A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)
Pfizer
GEN602
Genzada Pharmaceuticals USA, Inc.